Weighted Average Number of Shares Outstanding, Diluted of BioCorRx Inc. from 30 Sep 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
BioCorRx Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2011 to 30 Sep 2025.
  • BioCorRx Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 18,162,783, a 67% increase year-over-year.
  • BioCorRx Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 3,378,376, a 25% increase from 2023.
  • BioCorRx Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2,697,299, a 86% increase from 2022.
  • BioCorRx Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1,447,913, a 37% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

BioCorRx Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 18,162,783 +7,254,492 +67% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q1 2025 3,552,262 +611,338 +21% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2024 Q1
Q3 2024 10,908,291 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q1 2024 2,940,924 +1,141,947 +63% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2024 Q1
Q1 2023 1,798,977 +726,899 +68% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 1,072,078 -59,053 -5.2% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 1,131,131 -4,166 -0.37% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 1,135,297 -1,292,803 -53% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 2,428,100 +624,000 +35% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q2 2018 250,493,153 -329,175,549 -57% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 1,804,100 -354,109,086 -99% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q2 2017 579,668,702 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 355,913,186 +330,374,578 +1294% 01 Jan 2017 31 Mar 2017 10-Q 18 May 2018 2018 Q1
Q1 2016 25,538,608 +5,725,275 +29% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q2 2015 151,757,578 +9,758,455 +6.9% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 19,813,333 -774,532 -3.8% 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016 2016 Q1
Q2 2014 141,999,123 +25,375,677 +22% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 20,587,865 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q2 2013 116,623,446 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q3 2012 100,882,784 +63,882,784 +173% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2012 2012 Q3
Q3 2011 37,000,000 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012 2012 Q3

BioCorRx Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 3,378,376 +681,077 +25% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 2,697,299 +1,249,386 +86% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 1,447,913 +392,562 +37% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 1,055,351 -85,780 -7.5% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 1,141,131 +5,834 +0.51% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 1,135,297 -1,294,303 -53% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 2,429,600 +613,950 +34% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 1,815,650 -248,370,665 -99% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
2016 250,186,315 +223,392,590 +834% 01 Jan 2016 31 Dec 2016 10-K 05 Apr 2018 2017 FY
2015 26,793,725 +8,813,725 +49% 01 Jan 2015 31 Dec 2015 10-K 13 Apr 2017 2016 FY
2014 17,980,000 +2,180,000 +14% 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016 2015 FY
2013 15,800,000 -90,353,613 -85% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 106,153,613 +55,597,195 +110% 01 Jan 2012 31 Dec 2012 10-K 14 Apr 2014 2013 FY
2011 50,556,418 01 Jan 2011 31 Dec 2011 10-K 15 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.